Catalyst Wire Dossier Catalyst Wire Dossier

ABT-335

· Abbott
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for ABT-335, covering 2009-03-25 to 2014-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood [Phase 3]

See pricing